“…Among the various methods, transition-metal-catalyzed C–H borylation stands out 1–6 due to its versatility in converting C–B bonds into C–N, C–D, C–O, C–X, and C–C bonds. 7 In addition, organoboron compounds are widely used in biomarker discovery, 8,9 chemical sensing, 10 bioprobe development, 11 and molecular imaging. 12 Moreover, advancements in boron chemistry have propelled the use of boron-containing compounds in drug discovery, 13,14 exemplified by bortezomib, 15 the first FDA-approved boron-containing drug for treating multiple myeloma.…”